Reply: A Call for High-Level Evidence Before Routine Implementation of Posttreatment SPECT
REPLY: We appreciate the letter by Mulugeta et al. regarding our procedure standard on posttreatment imaging for 177Lu-based radiopharmaceutical therapies (RPTs) ([1][1]). Their emphasis on prospective evidence, access, workflow, and multidisciplinary care is important and welcome. Such discussion
Authors
- Stephen A. Graves (ORCID: https://orcid.org/0000-0003-2732-3064)
- Bital Savir-Baruch (ORCID: https://orcid.org/0000-0002-9589-9690)
- Yuni K. Dewaraja (ORCID: https://orcid.org/0000-0002-3920-6925)
- Courtney Lawhn Heath
- Carlos Uribe
- Heather Jacene
- Amir Iravani
- Thomas A. Hope
Publication Details
- Journal
- Journal of Nuclear Medicine
- Published
- 2026-05-21
- DOI
- https://doi.org/10.2967/jnumed.126.272083
- Primary Topic
- Radiopharmaceutical Chemistry and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00